This dataset contains information on the total proportion of adults diagnosed with diabetes, collected from the system of health-related telephone surveys, the Behavioral Risk Factor Surveillance System (BRFSS), conducted in more than 400,000 patients, from 50 states in the US, the District of Columbia and three US territories.
SUMMARYThis analysis, designed and executed by Ribble Rivers Trust, identifies areas across England with the greatest levels of diabetes mellitus in persons (aged 17+). Please read the below information to gain a full understanding of what the data shows and how it should be interpreted.ANALYSIS METHODOLOGYThe analysis was carried out using Quality and Outcomes Framework (QOF) data, derived from NHS Digital, relating to diabetes mellitus in persons (aged 17+).This information was recorded at the GP practice level. However, GP catchment areas are not mutually exclusive: they overlap, with some areas covered by 30+ GP practices. Therefore, to increase the clarity and usability of the data, the GP-level statistics were converted into statistics based on Middle Layer Super Output Area (MSOA) census boundaries.The percentage of each MSOA’s population (aged 17+) with diabetes mellitus was estimated. This was achieved by calculating a weighted average based on:The percentage of the MSOA area that was covered by each GP practice’s catchment areaOf the GPs that covered part of that MSOA: the percentage of registered patients that have that illness The estimated percentage of each MSOA’s population with diabetes mellitus was then combined with Office for National Statistics Mid-Year Population Estimates (2019) data for MSOAs, to estimate the number of people in each MSOA with depression, within the relevant age range.Each MSOA was assigned a relative score between 1 and 0 (1 = worst, 0 = best) based on:A) the PERCENTAGE of the population within that MSOA who are estimated to have diabetes mellitusB) the NUMBER of people within that MSOA who are estimated to have diabetes mellitusAn average of scores A & B was taken, and converted to a relative score between 1 and 0 (1= worst, 0 = best). The closer to 1 the score, the greater both the number and percentage of the population in the MSOA that are estimated to have diabetes mellitus, compared to other MSOAs. In other words, those are areas where it’s estimated a large number of people suffer from diabetes mellitus, and where those people make up a large percentage of the population, indicating there is a real issue with diabetes mellitus within the population and the investment of resources to address that issue could have the greatest benefits.LIMITATIONS1. GP data for the financial year 1st April 2018 – 31st March 2019 was used in preference to data for the financial year 1st April 2019 – 31st March 2020, as the onset of the COVID19 pandemic during the latter year could have affected the reporting of medical statistics by GPs. However, for 53 GPs (out of 7670) that did not submit data in 2018/19, data from 2019/20 was used instead. Note also that some GPs (997 out of 7670) did not submit data in either year. This dataset should be viewed in conjunction with the ‘Health and wellbeing statistics (GP-level, England): Missing data and potential outliers’ dataset, to determine areas where data from 2019/20 was used, where one or more GPs did not submit data in either year, or where there were large discrepancies between the 2018/19 and 2019/20 data (differences in statistics that were > mean +/- 1 St.Dev.), which suggests erroneous data in one of those years (it was not feasible for this study to investigate this further), and thus where data should be interpreted with caution. Note also that there are some rural areas (with little or no population) that do not officially fall into any GP catchment area (although this will not affect the results of this analysis if there are no people living in those areas).2. Although all of the obesity/inactivity-related illnesses listed can be caused or exacerbated by inactivity and obesity, it was not possible to distinguish from the data the cause of the illnesses in patients: obesity and inactivity are highly unlikely to be the cause of all cases of each illness. By combining the data with data relating to levels of obesity and inactivity in adults and children (see the ‘Levels of obesity, inactivity and associated illnesses: Summary (England)’ dataset), we can identify where obesity/inactivity could be a contributing factor, and where interventions to reduce obesity and increase activity could be most beneficial for the health of the local population.3. It was not feasible to incorporate ultra-fine-scale geographic distribution of populations that are registered with each GP practice or who live within each MSOA. Populations might be concentrated in certain areas of a GP practice’s catchment area or MSOA and relatively sparse in other areas. Therefore, the dataset should be used to identify general areas where there are high levels of diabetes mellitus, rather than interpreting the boundaries between areas as ‘hard’ boundaries that mark definite divisions between areas with differing levels of diabetes mellitus.TO BE VIEWED IN COMBINATION WITH:This dataset should be viewed alongside the following datasets, which highlight areas of missing data and potential outliers in the data:Health and wellbeing statistics (GP-level, England): Missing data and potential outliersLevels of obesity, inactivity and associated illnesses (England): Missing dataDOWNLOADING THIS DATATo access this data on your desktop GIS, download the ‘Levels of obesity, inactivity and associated illnesses: Summary (England)’ dataset.DATA SOURCESThis dataset was produced using:Quality and Outcomes Framework data: Copyright © 2020, Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital.GP Catchment Outlines. Copyright © 2020, Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital. Data was cleaned by Ribble Rivers Trust before use.COPYRIGHT NOTICEThe reproduction of this data must be accompanied by the following statement:© Ribble Rivers Trust 2021. Analysis carried out using data that is: Copyright © 2020, Health and Social Care Information Centre. The Health and Social Care Information Centre is a non-departmental body created by statute, also known as NHS Digital.CaBA HEALTH & WELLBEING EVIDENCE BASEThis dataset forms part of the wider CaBA Health and Wellbeing Evidence Base.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
India IN: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 19.800 NA in 2016. This records a decrease from the previous number of 20.000 NA for 2015. India IN: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 21.200 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 23.400 NA in 2000 and a record low of 19.800 NA in 2016. India IN: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s India – Table IN.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Nigeria NG: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 20.900 NA in 2016. This records an increase from the previous number of 20.800 NA for 2015. Nigeria NG: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 21.000 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 22.600 NA in 2000 and a record low of 20.800 NA in 2015. Nigeria NG: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Nigeria – Table NG.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;
This dataset tracks the updates made on the dataset "Public Health Statistics- Diabetes hospitalizations in Chicago, 2000 - 2011" as a repository for previous versions of the data and metadata.
Note: This dataset is historical only and there are not corresponding datasets for more recent time periods. For that more-recent information, please visit the Chicago Health Atlas at https://chicagohealthatlas.org. This dataset contains the annual number of hospital discharges, crude hospitalization rates with corresponding 95% confidence intervals, and age-adjusted hospitalization rates with corresponding 95% confidence intervals, for the years 2000 – 2011, by Chicago U.S. Postal Service ZIP code or ZIP code aggregate. See the full description at http://bit.ly/Os5wnn.
Rate: Age-adjusted death rate, number of deaths due to diabetes, per 100,000 population.
Definition: Deaths with diabetes as the underlying cause of death (ICD-10 codes: E10-E14).
Data Sources:
(1) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health
(2) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development
Health, United States is an annual report on trends in health statistics, find more information at http://www.cdc.gov/nchs/hus.htm.
This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated 8/14/2024.
Number of deaths among Maryland residents for which diabetes mellitus was the underlying cause of death. This includes deaths coded to the following International Classification of Diseases codes: ICD-3 (1920-1929) -- 57 ICD-4 (1930-1938) -- 59 ICD-5 (1939-1948) -- 61 ICD-6 (1949-1957) -- 260 ICD-7 (1958-1967) -- 260 ICD-8 (1968-1978) -- 250 ICD-9 (1979-1998) -- 250 ICD-10 (1999-present) -- E10-E14.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Ivory Coast CI: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 30.100 NA in 2016. This records a decrease from the previous number of 30.300 NA for 2015. Ivory Coast CI: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 29.800 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 30.300 NA in 2015 and a record low of 27.500 NA in 2000. Ivory Coast CI: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Ivory Coast – Table CI.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;
The projected number of patients suffering from diabetes in Indonesia is expected to reach about 9.5 million by 2024. In that year, the population growth will decline slightly but there will be an increase of the elderly over 65 years old. Alongside with the population structure, the prevalence of diseases changes proportionally.
Open Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
This table contains 14784 series, with data for years 1994 - 1998 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (not all combinations are available): Geography (11 items: Canada; Newfoundland and Labrador; Prince Edward Island; Nova Scotia ...), Age group (14 items: Total; 12 years and over; 15-19 years; 12-19 years; 12-14 years ...), Sex (3 items: Both sexes; Males; Females ...), Diabetes (4 items: Total population for the variable diabetes ;With diabetes; Without diabetes; Diabetes; not stated ...), Characteristics (8 items: Number of persons; Low 95% confidence interval - number of persons; High 95% confidence interval - number of persons; Coefficient of variation for number of persons ...).
Rank, number of deaths, percentage of deaths, and age-specific mortality rates for the leading causes of death, by age group and sex, 2000 to most recent year.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 17.500 NA in 2016. This records an increase from the previous number of 17.200 NA for 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 17.500 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 21.600 NA in 2000 and a record low of 17.200 NA in 2015. United States US: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Saudi Arabia SA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 16.400 % in 2016. This records a decrease from the previous number of 16.500 % for 2015. Saudi Arabia SA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 17.900 % from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 18.900 % in 2000 and a record low of 16.400 % in 2016. Saudi Arabia SA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Saudi Arabia – Table SA.World Bank: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted Average;
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This publication contains facts, mortality rates, trends and major causes of death by age group, sex, ethnicity and district health board for deaths registered in 2011. Cancer, ischaemic heart disease, cerebrovascular disease, diabetes mellitus, motor vehicle accidents and suicide deaths are analysed and reviewed in more detail. Where possible, time trends from 1950 are included.
Population-based county-level estimates for prevalence of DC were obtained from the Institute for Health Metrics and Evaluation (IHME) for the years 2004-2012 (16). DC prevalence rate was defined as the propor-tion of people within a county who had previously been diagnosed with diabetes (high fasting plasma glu-cose 126 mg/dL, hemoglobin A1c (HbA1c) of 6.5%, or diabetes diagnosis) but do not currently have high fasting plasma glucose or HbA1c for the period 2004-2012. DC prevalence estimates were calculated using a two-stage approach. The first stage used National Health and Nutrition Examination Survey (NHANES) data to predict high fasting plasma glucose (FPG) levels (≥126 mg/dL) and/or HbA1C levels (≥6.5% [48 mmol/mol]) based on self-reported demographic and behavioral characteristics (16). This model was then applied to Behavioral Risk Factor Surveillance System (BRFSS) data to impute high FPG and/or HbA1C status for each BRFSS respondent (16). The second stage used the imputed BRFSS data to fit a series of small area models, which were used to predict county-level prevalence of diabetes-related outcomes, including DC (16). The EQI was constructed for 2006-2010 for all US counties and is composed of five domains (air, water, built, land, and sociodemographic), each composed of variables to represent the environmental quality of that domain. Domain-specific EQIs were developed using principal components analysis (PCA) to reduce these variables within each domain while the overall EQI was constructed from a second PCA from these individual domains (L. C. Messer et al., 2014). To account for differences in environment across rural and urban counties, the overall and domain-specific EQIs were stratified by rural urban continuum codes (RUCCs) (U.S. Department of Agriculture, 2015). Results are reported as prevalence rate differences (PRD) with 95% confidence intervals (CIs) comparing the highest quintile/worst environmental quality to the lowest quintile/best environmental quality expo-sure metrics. PRDs are representative of the entire period of interest, 2004-2012. Due to availability of DC data and covariate data, not all counties were captured, however, the majority, 3134 of 3142 were utilized in the analysis. This dataset is not publicly accessible because: EPA cannot release personally identifiable information regarding living individuals, according to the Privacy Act and the Freedom of Information Act (FOIA). This dataset contains information about human research subjects. Because there is potential to identify individual participants and disclose personal information, either alone or in combination with other datasets, individual level data are not appropriate to post for public access. Restricted access may be granted to authorized persons by contacting the party listed. It can be accessed through the following means: Human health data are not available publicly. EQI data are available at: https://edg.epa.gov/data/Public/ORD/NHEERL/EQI. Format: Data are stored as csv files. This dataset is associated with the following publication: Jagai, J., A. Krajewski, K. Price, D. Lobdell, and R. Sargis. Diabetes control is associated with environmental quality in the USA. Endocrine Connections. BioScientifica Ltd., Bristol, UK, 10(9): 1018-1026, (2021).
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
China Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data was reported at 14.100 NA in 2016. This records a decrease from the previous number of 14.400 NA for 2015. China Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data is updated yearly, averaging 15.100 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 18.100 NA in 2000 and a record low of 14.100 NA in 2016. China Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Female data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s China – Table CN.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;
The National Health and Nutrition Examination Survey (NHANES) is a program of studies designed to assess the health and nutritional status of adults and children in the United States. The survey is unique in that it combines interviews and physical examinations. NHANES is a major program of the National Center for Health Statistics (NCHS). NCHS is part of the Centers for Disease Control and Prevention (CDC) and has the responsibility for producing vital and health statistics for the Nation.
The NHANES program began in the early 1960s and has been conducted as a series of surveys focusing on different population groups or health topics. In 1999, the survey became a continuous program that has a changing focus on a variety of health and nutrition measurements to meet emerging needs. The survey examines a nationally representative sample of about 5,000 persons each year. These persons are located in counties across the country, 15 of which are visited each year.
The NHANES interview includes demographic, socioeconomic, dietary, and health-related questions. The examination component consists of medical, dental, and physiological measurements, as well as laboratory tests administered by highly trained medical personnel.
To date, thousands of research findings have been published using the NHANES data.
The 2013-2014 NHANES datasets include the following components:
Blood pressure
Body measures
Muscle strength - grip test
Oral health - dentition
Taste & smell
A complete variable dictionary can be found here
Albumin & Creatinine - Urine
Apolipoprotein B
Blood Lead, Cadmium, Total Mercury, Selenium, and Manganese
Blood mercury: inorganic, ethyl and methyl
Cholesterol - HDL
Cholesterol - LDL & Triglycerides
Cholesterol - Total
Complete Blood Count with 5-part Differential - Whole Blood
Copper, Selenium & Zinc - Serum
Fasting Questionnaire
Fluoride - Plasma
Fluoride - Water
Glycohemoglobin
Hepatitis A
Hepatitis B Surface Antibody
Hepatitis B: core antibody, surface antigen, and Hepatitis D antibody
Hepatitis C RNA (HCV-RNA) and Hepatitis C Genotype
Hepatitis E: IgG & IgM Antibodies
Herpes Simplex Virus Type-1 & Type-2
HIV Antibody Test
Human Papillomavirus (HPV) - Oral Rinse
Human Papillomavirus (HPV) DNA - Vaginal Swab: Roche Cobas & Roche Linear Array
Human Papillomavirus (HPV) DNA Results from Penile Swab Samples: Roche Linear Array
Insulin
Iodine - Urine
Perchlorate, Nitrate & Thiocyanate - Urine
Perfluoroalkyl and Polyfluoroalkyl Substances (formerly Polyfluoroalkyl Chemicals - PFC)
Personal Care and Consumer Product Chemicals and Metabolites
Phthalates and Plasticizers Metabolites - Urine
Plasma Fasting Glucose
Polycyclic Aromatic Hydrocarbons (PAH) - Urine
Standard Biochemistry Profile
Tissue Transglutaminase Assay (IgA-TTG) & IgA Endomyseal Antibody Assay (IgA EMA)
Trichomonas - Urine
Two-hour Oral Glucose Tolerance Test
Urinary Chlamydia
Urinary Mercury
Urinary Speciated Arsenics
Urinary Total Arsenic
Urine Flow Rate
Urine Metals
Urine Pregnancy Test
Vitamin B12
A complete data dictionary can be found here
Acculturation
Alcohol Use
Blood Pressure & Cholesterol
Cardiovascular Health
Consumer Behavior
Current Health Status
Dermatology
Diabetes
Diet Behavior & Nutrition
Disability
Drug Use
Early Childhood
Food Security
Health Insurance
Hepatitis
Hospital Utilization & Access to Care
Housing Characteristics
Immunization
Income
Medical Conditions
Mental Health - Depression Screener
Occupation
Oral Health
Osteoporosis
Pesticide Use
Physical Activity
Physical Functioning
Preventive Aspirin Use
Reproductive Health
Sexual Behavior
Sleep Disorders
Smoking - Cigarette Use
Smoking - Household Smokers
Smoking - Recent Tobacco Use
Smoking - Secondhand Smoke Exposure
Taste & Smell
Weight History
Weight History - Youth
A complete variable dictionary can be found here
Original data and additional documents related to the datasets or NHANES can be found here.
Decrease the percentage of people with Type 2 diabetes from 11.2% in 2014 to 10.1% by 2019.
This dataset contains information on the total proportion of adults diagnosed with diabetes, collected from the system of health-related telephone surveys, the Behavioral Risk Factor Surveillance System (BRFSS), conducted in more than 400,000 patients, from 50 states in the US, the District of Columbia and three US territories.